Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 December 2023 | Story Anthony Mthembu | Photo SUPPLIED
Albertus Engelbrecht
Albertus Engelbrecht: Lecturer in Singing and Coordinator of Vocal Studies at the Odeion School of Music.

The University of the Free State (UFS) is gearing up to honour a new group of graduates during the upcoming graduation ceremonies on 7-8 December 2023. Among the distinguished individuals set to grace the stage is Albertus Engelbrecht, Coordinator of Vocal Studies at the Odeion School of Music and an internationally recognised opera singer with a career spanning over two decades.

Engelbrecht has achieved a significant milestone, completing his PhD thesis titled “The Journey of a Versatile Singer”. On 7 December 2023, he will formally receive his qualification, marking the culmination of a seven-year academic journey. Reflecting on this achievement, Engelbrecht expressed his relief, stating, “It’s all still so surreal, but I think that the moment I walk onto that stage, then, will it only sink in.’’  

The journey of a versatile singer

His thesis is an auto-ethnographic study that delves into the preparation and performance of five different styles and genres of Western art music. This unique approach includes a practical component, as he actively participated in five different concerts or performances, ultimately contributing to his research. He shared his motivation, stating, ‘’I was investigating how it would be possible to sing different kinds of Western art music styles and genres. The idea came from my professional experience, where I found that to become a successful opera and concert singer, it’s better for one to be able to do different styles and genres.’’  

Looking ahead, Engelbrecht envisions his research making a meaningful impact on the development of emerging singers. He aspires to shape the future of vocal education, stating, “I hope that my contribution leads to new knowledge not only for singers but for their teachers and vocal coaches. This is so that they can approach music in the way it is written, and to find ways which make the music speak the best way it can. In this way, singers can be more versatile.’’  

Future plans

Post-graduation, Engelbrecht has ambitious plans to further his growth within the industry. Expressing his goals, he said, ‘’I would like to grow not just as a performing artist but as a researcher too.” Currently collaborating with his former supervisor on a research project focusing on performance analysis, Engelbrecht aims to delve deeper into the research aspect of his profession. Additionally, as a Lecturer of Singing at the UFS, he looks forward to engaging in more performing projects with his students.

In recognition of Albertus Engelbrecht’s remarkable achievement, the UFS community congratulates him on this significant milestone. His dedication to the field of vocal studies and commitment to fostering versatility in music is truly commendable. 

News Archive

Champagne and cancer have more in common than you might think
2013-05-08

 

Photo: Supplied
08 May 2013

No, a glass of champagne will not cure cancer....

…But they have more in common than you might think.

Researchers from the Departments of Microbial Biochemical and Food Biotechnology, Physics and the Centre for Microscopy at the University of the Free State in South Africa were recently exploring the properties of yeast cells in wine and food to find out more of how yeast was able to manufacture the gas that caused bread to rise, champagne to fizz and traditional beer to foam. And the discovery they made is a breakthrough that may have enormous implications for the treatment of diseases in humans.

The team discovered that they could slice open cells with argon gas particles, and look inside. They were surprised to find a maze of tiny passages like gas chambers that allowed each cell to ‘breathe.’ It is this tiny set of ‘lungs’ that puts the bubbles in your bubbly and the bounce in your bread.

But it was the technique that the researchers used to open up the cells that caught the attention of the scientists at the Mayo Clinic (Tumor Angiogenesis and Vascular Biology Research Centre) in the US.

Using this technology, they ultimately aim to peer inside cells taken from a cancer patient to see how treatment was progressing. In this way they would be able to assist the Mayo team to target treatments more effectively, reduce dosages in order to make treatment gentler on the patient, and have an accurate view of how the cancer was being eliminated.

“Yes, we are working with the Mayo Clinic,” said Profes Lodewyk Kock from the Microbial, Biochemical and Food Biotechnology Department at the UFS.

“This technique we developed has enormous potential for cell research, whether it is for cancer treatment or any other investigation into the working of cells. Through nanotechnology, and our own invention called Auger-architectomics, we are able to see where no-one has been able to see before.”

The team of Prof Kock including Dr Chantel Swart, Kumisho Dithebe, Prof Hendrik Swart (Physics, UFS) and Prof Pieter van Wyk (Centre for Microscopy, UFS) unlocked the ‘missing link’ that explains the existence of bubbles inside yeasts, and incidentally have created a possible technique for tracking drug and chemotherapy treatment in human cells.

Their work has been published recently in FEMS Yeast Research, the leading international journal on yeast research. In addition, their discovery has been selected for display on the cover page of all 2013 issues of this journal.

One can most certainly raise a glass of champagne to celebrate that!

There are links for video lectures on the technique used and findings on the Internet at:

1. http://vimeo.com/63643628 (Comic version for school kids)

2. http://vimeo.com/61521401 (Detailed version for fellow scientists)

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept